Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 441(4): 923-8, 2013 Nov 29.
Article in English | MEDLINE | ID: mdl-24216105

ABSTRACT

Mammalian target of rapamycin (mTOR) complex is a key regulator of autophagy, cell growth and proliferation. Here, we studied the effects of arginine vasopressin (AVP) on mTOR activation in vascular smooth muscle cells cultured in high glucose concentration. AVP induced the mTOR phosphorylation in A-10 cells grown in high glucose, in contrast to cells cultured in normal glucose; wherein, only basal phosphorylation was observed. The AVP-induced mTOR phosphorylation was inhibited by a PI3K inhibitor. Moreover, the AVP-induced mTOR activation inhibited autophagy and increased thymidine incorporation in cells grown in high glucose. This increase was abolished by rapamycin which inhibits the mTORC1 complex formation. Our results suggest that AVP stimulates mTOR phosphorylation by activating the PI3K/Akt signaling pathway and, subsequently, inhibits autophagy and raises cell proliferation in A-10 cells maintained in high glucose concentration.


Subject(s)
Arginine Vasopressin/pharmacology , Glucose/metabolism , Hyperglycemia/enzymology , Multiprotein Complexes/metabolism , Myocytes, Smooth Muscle/drug effects , Proto-Oncogene Proteins c-akt/metabolism , TOR Serine-Threonine Kinases/metabolism , Animals , Cell Line , Chromones/pharmacology , Glucose/pharmacology , Mechanistic Target of Rapamycin Complex 1 , Morpholines/pharmacology , Myocytes, Smooth Muscle/enzymology , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...